KOHL  WE CAN TEAR DOWN THE BARRIERS THAT SLOW GENERIC DRUGS                    Press Release      For Immediate Release    July 20  2006    Phone   202  224 5653        KOHL  WE CAN TEAR DOWN THE BARRIERS THAT SLOW GENERIC DRUGS     Washington  DC    U S  Senator Herb Kohl  D WI   Ranking Member of the Special Committee on Aging  today held a hearing to examine the bureaucratic and legal barriers that stop new generic drugs from entering the market  Generic medicines offer affordable alternatives to pricier name brand drugs  reducing the financial burden on both senior citizens and the government health programs that serve them     The pharmaceutical industry remains one of the most profitable industries in the world  returning more that 15  on their investment   Kohl said   But they are charging Americans the highest drug prices in the world  forcing some employers to drop health coverage for their employees and squeezing the budgets of state and federal governments   At the hearing  Kohl questioned Gary Buehler  Director of the FDA s Office of Generic Drugs  on his department s efforts to address the growing generic application backlog in the face of mounting drug applications  frivolous citizen petitions  and significant budget cuts  Earlier this year  Kohl successfully added  10 million to FDA s budget to expedite generic drug review in the Senate s FY 2007 Agriculture Appropriations bill  Kohl also cited  payoff settlements  as another obstacle that keeps generics off pharmacy shelves   Payoff settlements occur when a brand name drug company pays a generic drug maker to delay the sale of their competing generic drug   Last month  Kohl introduced legislation  the Preserve Access to Affordable Generics Act  to prohibit this anti competitive scheme  The Congressional Budget Office has estimated that generics save consumers between  8 and  10 billion each year at retail pharmacies   The use of generic drugs in hospitals provides savings of additional billions of dollars  Kohl added   We have to do more to bring these affordable medicines to the market  They will help individuals cope with soaring health care costs and help the federal government save money in Medicare and Medicaid   Kohl is also the senior Democrat on the Agriculture Appropriations Subcommittee  which has jurisdiction over the FDA s budget                     